Cannabis biotech firm Front Range Biosciences locks in $10 mln Series A
Lafayette, Colorado-based Front Range Biosciences, a cannabis biotech company, has raised $10 million in Series A financing. The investors included Phyto Partners, WelCan Capital, Salveo Capital, Cornerstone Opportunity Partners, Sand Hill Angels, Harvard Business School Alumni Angels of New York, New York Angels and Altitude Investment Management.
5 October 2018•1 min read
